Home
Conditions
Parkinsonian Disorders

Clinical trial condition

Parkinsonian Disorders

Explore clinical trials studying Parkinsonian Disorders. Study availability and eligibility vary by location and protocol.

3,328 public trials 611 recruiting studies

Refine in advanced search Browse all conditions

Parkinsonian Disorders trial results

Completed

Efficacy and Tolerability of Nebicapone in Parkinson's Disease Patients With "Wearingoff" Phenomenon

NCT03103399

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Not specified

View Trial Details

Completed

Impact of Rehabilitation in Quality of Life in PD

NCT02756676

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Department of Parkinson's Disease and Brain Injury Rehabilitation, of the 'Moriggia-Pelascini' Hospital Gradevole Ed Uniti, Como, Italy

View Trial Details

Completed

Efficacy of Pain Treatment on Depression in Patients With Dementia

NCT02267057

Conditions: Agnosia, Alzheimer Disease, Arterial Occlusive Diseases, +44 more
Locations: University of Bergen Bergen, Norway

View Trial Details

Completed

Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics With a Single-dose of Levodopa/Benserazide 200/50 mg or With a Single-dose of Levodopa/Benserazide 200/50 mg Plus a Single-dose of Nebicapone 150 mg

NCT03097211

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Human Pharmacology Unit (UFH) - BIAL - Portela & Cª, SA S. Mamede Do Coronado, Portugal

View Trial Details

Completed

Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics

NCT03094156

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Human Pharmacology Unit (UFH) - BIAL - Portela & Cª, SA S. Mamede Do Coronado, Portugal

View Trial Details

Completed

Effects of Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's Disease

NCT00219284

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +12 more
Locations: Phoenix, Arizona, United States

Fullerton, California, United States

Irvine, California, United States

La Jolla, California, United States

View all 42 locations

View Trial Details

Completed

Pharmacokinetic Profile of BIA 6-512 in Healthy Elderly Subjects Versus Healthy Young Subjects

NCT03095105

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Scope International AG Hamburg, Germany

View Trial Details

Completed

Blood Lactate Concentrations With and Without Exercise in Parkinson's Disease and Multiple Sclerosis Patients

NCT02184494

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Basal Ganglia Diseases, +18 more
Locations: Fitness and Wellness Center Tallahassee, Florida, United States

Balance Disorders Clinic Tallahassee, Florida, United States

View Trial Details

Completed

Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States

NCT00143026

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Royal Adelaide Hospital Adelaide, Australia

Watkins Medical Center Brisbane, Australia

Central Coast Neuroscience Research Gosford, Australia

Heidelberg Repatriation Hospital Melbourne, Australia

View all 18 locations

View Trial Details

Completed

Effect of Food on BIA 6-512 (Trans-resveratrol)

NCT03095092

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Human Pharmacology Unit (UFH) - BIAL - Portela & Cª, SA S. Mamede Do Coronado, Portugal

View Trial Details

Parkinsonian Disorders

Parkinsonian Disorders trial results

Related conditions